<?xml version="1.0" encoding="UTF-8"?>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" dtd-version="1.0" article-type="reference-list">
<front>
<article-meta>
<custom-meta-group>
<custom-meta><meta-name>TotalReferences</meta-name><meta-value>30</meta-value></custom-meta>
<custom-meta><meta-name>ReferencesParsed</meta-name><meta-value>29</meta-value></custom-meta>
<custom-meta><meta-name>ReferencesBillable</meta-name><meta-value>29</meta-value></custom-meta>
<custom-meta><meta-name>LinkServices</meta-name><meta-value>pubmed-crossref</meta-value></custom-meta>
<custom-meta><meta-name>ReferencesLinked</meta-name><meta-value>28</meta-value></custom-meta>
<custom-meta><meta-name>ReferencesLinkedDOI</meta-name><meta-value>28</meta-value></custom-meta>
<custom-meta><meta-name>ReferencesLinkedPMID</meta-name><meta-value>28</meta-value></custom-meta>
<custom-meta><meta-name>JournalReferences</meta-name><meta-value>29</meta-value></custom-meta>
<custom-meta><meta-name>BookReferences</meta-name><meta-value>0</meta-value></custom-meta>
<custom-meta><meta-name>BookChapterReferences</meta-name><meta-value>0</meta-value></custom-meta>
<custom-meta><meta-name>ConferenceReferences</meta-name><meta-value>0</meta-value></custom-meta>
<custom-meta><meta-name>ElectronicReferences</meta-name><meta-value>0</meta-value></custom-meta>
<custom-meta><meta-name>DissertationReferences</meta-name><meta-value>0</meta-value></custom-meta>
<custom-meta><meta-name>LegalReferences</meta-name><meta-value>0</meta-value></custom-meta>
<custom-meta><meta-name>StandardReferences</meta-name><meta-value>0</meta-value></custom-meta>
<custom-meta><meta-name>OtherReferences</meta-name><meta-value>0</meta-value></custom-meta>
<custom-meta><meta-name>UnknownReferences</meta-name><meta-value>1</meta-value></custom-meta>
<custom-meta><meta-name>ReferencesSemiParsed</meta-name><meta-value>0</meta-value></custom-meta>
<custom-meta><meta-name>ReferencesBookUnparsed</meta-name><meta-value>0</meta-value></custom-meta>
<custom-meta><meta-name>EditorialStyle</meta-name><meta-value>ICMJE-WHO</meta-value></custom-meta>
</custom-meta-group>
</article-meta>
</front>
<back>
<ref-list>
<ref id="b1"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Weinstein</surname> <given-names>RS</given-names></string-name></person-group>. <article-title>Clinical practice. Glucocorticoid-induced bone disease</article-title>. <source>N Engl J Med</source>. <year>2011</year> <month>Jul</month>;<volume>365</volume>(<issue>1</issue>):<fpage>62</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMcp1012926</pub-id><pub-id pub-id-type="pmid">21732837</pub-id><issn>0028-4793</issn></mixed-citation></ref>
<ref id="b2"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Kanis</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Borgstrom</surname> <given-names>F</given-names></string-name>, <string-name><surname>De Laet</surname> <given-names>C</given-names></string-name>, <string-name><surname>Johansson</surname> <given-names>H</given-names></string-name>, <string-name><surname>Johnell</surname> <given-names>O</given-names></string-name>, <string-name><surname>Jonsson</surname> <given-names>B</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Assessment of fracture risk</article-title>. <source>Osteoporos Int</source>. <year>2005</year> <month>Jun</month>;<volume>16</volume>(<issue>6</issue>):<fpage>581</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1007/s00198-004-1780-5</pub-id><pub-id pub-id-type="pmid">15616758</pub-id><issn>0937-941X</issn></mixed-citation></ref>
<ref id="b3"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Lekamwasam</surname> <given-names>S</given-names></string-name>, <string-name><surname>Adachi</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Agnusdei</surname> <given-names>D</given-names></string-name>, <string-name><surname>Bilezikian</surname> <given-names>J</given-names></string-name>, <string-name><surname>Boonen</surname> <given-names>S</given-names></string-name>, <string-name><surname>Borgström</surname> <given-names>F</given-names></string-name>, <etal>et al.</etal>; <collab>Joint IOF-ECTS GIO Guidelines Working Group</collab></person-group>. <article-title>A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis</article-title>. <source>Osteoporos Int</source>. <year>2012</year> <month>Sep</month>;<volume>23</volume>(<issue>9</issue>):<fpage>2257</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1007/s00198-012-1958-1</pub-id><pub-id pub-id-type="pmid">22434203</pub-id><issn>0937-941X</issn></mixed-citation></ref>
<ref id="b4"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Grossman</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Gordon</surname> <given-names>R</given-names></string-name>, <string-name><surname>Ranganath</surname> <given-names>VK</given-names></string-name>, <string-name><surname>Deal</surname> <given-names>C</given-names></string-name>, <string-name><surname>Caplan</surname> <given-names>L</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>W</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis</article-title>. <source>Arthritis Care Res (Hoboken)</source>. <year>2010</year> <month>Nov</month>;<volume>62</volume>(<issue>11</issue>):<fpage>1515</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1002/acr.20295</pub-id><pub-id pub-id-type="pmid">20662044</pub-id><issn>2151-464X</issn></mixed-citation></ref>
<ref id="b5"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Buckley</surname> <given-names>L</given-names></string-name>, <string-name><surname>Guyatt</surname> <given-names>G</given-names></string-name>, <string-name><surname>Fink</surname> <given-names>HA</given-names></string-name>, <string-name><surname>Cannon</surname> <given-names>M</given-names></string-name>, <string-name><surname>Grossman</surname> <given-names>J</given-names></string-name>, <string-name><surname>Hansen</surname> <given-names>KE</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis</article-title>. <source>Arthritis Care Res (Hoboken)</source>. <year>2017</year> <month>Aug</month>;<volume>69</volume>(<issue>8</issue>):<fpage>1095</fpage>–<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1002/acr.23279</pub-id><pub-id pub-id-type="pmid">28585410</pub-id><issn>2151-464X</issn></mixed-citation></ref>
<ref id="b6"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Rizzoli</surname> <given-names>R</given-names></string-name>, <string-name><surname>Biver</surname> <given-names>E</given-names></string-name></person-group>. <article-title>Glucocorticoid-induced osteoporosis: who to treat with what agent?</article-title> <source>Nat Rev Rheumatol</source>. <year>2015</year> <month>Feb</month>;<volume>11</volume>(<issue>2</issue>):<fpage>98</fpage>–<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1038/nrrheum.2014.188</pub-id><pub-id pub-id-type="pmid">25385412</pub-id><issn>1759-4790</issn></mixed-citation></ref>
<ref id="b7"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Hansen</surname> <given-names>KE</given-names></string-name>, <string-name><surname>Wilson</surname> <given-names>HA</given-names></string-name>, <string-name><surname>Zapalowski</surname> <given-names>C</given-names></string-name>, <string-name><surname>Fink</surname> <given-names>HA</given-names></string-name>, <string-name><surname>Minisola</surname> <given-names>S</given-names></string-name>, <string-name><surname>Adler</surname> <given-names>RA</given-names></string-name></person-group>. <article-title>Uncertainties in the prevention and treatment of glucocorticoid-induced osteoporosis</article-title>. <source>J Bone Miner Res</source>. <year>2011</year> <month>Sep</month>;<volume>26</volume>(<issue>9</issue>):<fpage>1989</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1002/jbmr.362</pub-id><pub-id pub-id-type="pmid">21721042</pub-id><issn>0884-0431</issn></mixed-citation></ref>
<ref id="b8"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Díez-Pérez</surname> <given-names>A</given-names></string-name>, <string-name><surname>Hooven</surname> <given-names>FH</given-names></string-name>, <string-name><surname>Adachi</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Adami</surname> <given-names>S</given-names></string-name>, <string-name><surname>Anderson</surname> <given-names>FA</given-names></string-name>, <string-name><surname>Boonen</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal>; <collab>The Global Longitudinal Study of Osteoporosis in Women (GLOW)</collab></person-group>. <article-title>Regional differences in treatment for osteoporosis</article-title>. <source>Bone</source>. <year>2011</year> <month>Sep</month>;<volume>49</volume>(<issue>3</issue>):<fpage>493</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.bone.2011.05.007</pub-id><pub-id pub-id-type="pmid">21605715</pub-id><issn>8756-3282</issn></mixed-citation></ref>
<ref id="b9"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Amiche</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Albaum</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Tadrous</surname> <given-names>M</given-names></string-name>, <string-name><surname>Pechlivanoglou</surname> <given-names>P</given-names></string-name>, <string-name><surname>Lévesque</surname> <given-names>LE</given-names></string-name>, <string-name><surname>Adachi</surname> <given-names>JD</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials</article-title>. <source>Osteoporos Int</source>. <year>2016</year> <month>May</month>;<volume>27</volume>(<issue>5</issue>):<fpage>1709</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1007/s00198-015-3455-9</pub-id><pub-id pub-id-type="pmid">26694595</pub-id><issn>0937-941X</issn></mixed-citation></ref>
<ref id="b10"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Feldstein</surname> <given-names>AC</given-names></string-name>, <string-name><surname>Elmer</surname> <given-names>PJ</given-names></string-name>, <string-name><surname>Nichols</surname> <given-names>GA</given-names></string-name>, <string-name><surname>Herson</surname> <given-names>M</given-names></string-name></person-group>. <article-title>Practice patterns in patients at risk for glucocorticoid-induced osteoporosis</article-title>. <source>Osteoporos Int</source>. <year>2005</year> <month>Dec</month>;<volume>16</volume>(<issue>12</issue>):<fpage>2168</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1007/s00198-005-2016-z</pub-id><pub-id pub-id-type="pmid">16142501</pub-id><issn>0937-941X</issn></mixed-citation></ref>
<ref id="b11"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Mirza</surname> <given-names>F</given-names></string-name>, <string-name><surname>Canalis</surname> <given-names>E</given-names></string-name></person-group>. <article-title>Management of endocrine disease: Secondary osteoporosis: pathophysiology and management</article-title>. <source>Eur J Endocrinol</source>. <year>2015</year> <month>Sep</month>;<volume>173</volume>(<issue>3</issue>):<fpage>R131</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1530/EJE-15-0118</pub-id><pub-id pub-id-type="pmid">25971649</pub-id><issn>0804-4643</issn></mixed-citation></ref>
<ref id="b12"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Kanis</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Johnell</surname> <given-names>O</given-names></string-name>, <string-name><surname>Oden</surname> <given-names>A</given-names></string-name>, <string-name><surname>Johansson</surname> <given-names>H</given-names></string-name>, <string-name><surname>McCloskey</surname> <given-names>E</given-names></string-name></person-group>. <article-title>FRAX and the assessment of fracture probability in men and women from the UK</article-title>. <source>Osteoporos Int</source>. <year>2008</year> <month>Apr</month>;<volume>19</volume>(<issue>4</issue>):<fpage>385</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1007/s00198-007-0543-5</pub-id><pub-id pub-id-type="pmid">18292978</pub-id><issn>0937-941X</issn></mixed-citation></ref>
<ref id="b13"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Kanis</surname> <given-names>JA</given-names></string-name>, <string-name><surname>McCloskey</surname> <given-names>EV</given-names></string-name>, <string-name><surname>Johansson</surname> <given-names>H</given-names></string-name>, <string-name><surname>Cooper</surname> <given-names>C</given-names></string-name>, <string-name><surname>Rizzoli</surname> <given-names>R</given-names></string-name>, <string-name><surname>Reginster</surname> <given-names>JY</given-names></string-name>; <collab>Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF)</collab></person-group>. <article-title>European guidance for the diagnosis and management of osteoporosis in postmenopausal women</article-title>. <source>Osteoporos Int</source>. <year>2013</year> <month>Jan</month>;<volume>24</volume>(<issue>1</issue>):<fpage>23</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1007/s00198-012-2074-y</pub-id><pub-id pub-id-type="pmid">23079689</pub-id><issn>0937-941X</issn></mixed-citation></ref>
<ref id="b14"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Kanis</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Hans</surname> <given-names>D</given-names></string-name>, <string-name><surname>Cooper</surname> <given-names>C</given-names></string-name>, <string-name><surname>Baim</surname> <given-names>S</given-names></string-name>, <string-name><surname>Bilezikian</surname> <given-names>JP</given-names></string-name>, <string-name><surname>Binkley</surname> <given-names>N</given-names></string-name>, <etal>et al.</etal>; <collab>Task Force of the FRAX Initiative</collab></person-group>. <article-title>Interpretation and use of FRAX in clinical practice</article-title>. <source>Osteoporos Int</source>. <year>2011</year> <month>Sep</month>;<volume>22</volume>(<issue>9</issue>):<fpage>2395</fpage>–<lpage>411</lpage>. <pub-id pub-id-type="doi">10.1007/s00198-011-1713-z</pub-id><pub-id pub-id-type="pmid">21779818</pub-id><issn>0937-941X</issn></mixed-citation></ref>
<ref id="b15"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Kanis</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Johansson</surname> <given-names>H</given-names></string-name>, <string-name><surname>Oden</surname> <given-names>A</given-names></string-name>, <string-name><surname>McCloskey</surname> <given-names>EV</given-names></string-name></person-group>. <article-title>Guidance for the adjustment of FRAX according to the dose of glucocorticoids</article-title>. <source>Osteoporos Int</source>. <year>2011</year> <month>Mar</month>;<volume>22</volume>(<issue>3</issue>):<fpage>809</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1007/s00198-010-1524-7</pub-id><pub-id pub-id-type="pmid">21229233</pub-id><issn>0937-941X</issn></mixed-citation></ref>
<ref id="b16"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Briot</surname> <given-names>K</given-names></string-name>, <string-name><surname>Roux</surname> <given-names>C</given-names></string-name></person-group>. <article-title>Glucocorticoid-induced osteoporosis</article-title>. <source>RMD Open</source>. <year>2015</year> <month>Apr</month>;<volume>1</volume>(<issue>1</issue>):<fpage>e000014</fpage>. <pub-id pub-id-type="doi">10.1136/rmdopen-2014-000014</pub-id><pub-id pub-id-type="pmid">26509049</pub-id><issn>2399-4983</issn></mixed-citation></ref>
<ref id="b17"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Tatsuno</surname> <given-names>I</given-names></string-name>, <string-name><surname>Sugiyama</surname> <given-names>T</given-names></string-name>, <string-name><surname>Suzuki</surname> <given-names>S</given-names></string-name>, <string-name><surname>Yoshida</surname> <given-names>T</given-names></string-name>, <string-name><surname>Tanaka</surname> <given-names>T</given-names></string-name>, <string-name><surname>Sueishi</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Age dependence of early symptomatic vertebral fracture with high-dose glucocorticoid treatment for collagen vascular diseases</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2009</year> <month>May</month>;<volume>94</volume>(<issue>5</issue>):<fpage>1671</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2008-1578</pub-id><pub-id pub-id-type="pmid">19258412</pub-id><issn>0021-972X</issn></mixed-citation></ref>
<ref id="b18"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Genant</surname> <given-names>HK</given-names></string-name>, <string-name><surname>Engelke</surname> <given-names>K</given-names></string-name>, <string-name><surname>Fuerst</surname> <given-names>T</given-names></string-name>, <string-name><surname>Glüer</surname> <given-names>CC</given-names></string-name>, <string-name><surname>Grampp</surname> <given-names>S</given-names></string-name>, <string-name><surname>Harris</surname> <given-names>ST</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Noninvasive assessment of bone mineral and structure: state of the art</article-title>. <source>J Bone Miner Res</source>. <year>1996</year> <month>Jun</month>;<volume>11</volume>(<issue>6</issue>):<fpage>707</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1002/jbmr.5650110602</pub-id><pub-id pub-id-type="pmid">8725168</pub-id><issn>0884-0431</issn></mixed-citation></ref>
<ref id="b19"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Van Staa</surname> <given-names>TP</given-names></string-name>, <string-name><surname>Laan</surname> <given-names>RF</given-names></string-name>, <string-name><surname>Barton</surname> <given-names>IP</given-names></string-name>, <string-name><surname>Cohen</surname> <given-names>S</given-names></string-name>, <string-name><surname>Reid</surname> <given-names>DM</given-names></string-name>, <string-name><surname>Cooper</surname> <given-names>C</given-names></string-name></person-group>. <article-title>Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy</article-title>. <source>Arthritis Rheum</source>. <year>2003</year> <month>Nov</month>;<volume>48</volume>(<issue>11</issue>):<fpage>3224</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/art.11283</pub-id><pub-id pub-id-type="pmid">14613287</pub-id><issn>0004-3591</issn></mixed-citation></ref>
<ref id="b20"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><collab>American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis</collab></person-group>. <article-title>Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update</article-title>. <source>Arthritis Rheum</source>. <year>2001</year> <month>Jul</month>;<volume>44</volume>(<issue>7</issue>):<fpage>1496</fpage>–<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1002/1529-0131(200107)44:7&lt;1496::AID-ART271&gt;3.0.CO;2-5</pub-id><pub-id pub-id-type="pmid">11465699</pub-id><issn>0004-3591</issn></mixed-citation></ref>
<ref id="b21"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Ulivieri</surname> <given-names>FM</given-names></string-name>, <string-name><surname>Silva</surname> <given-names>BC</given-names></string-name>, <string-name><surname>Sardanelli</surname> <given-names>F</given-names></string-name>, <string-name><surname>Hans</surname> <given-names>D</given-names></string-name>, <string-name><surname>Bilezikian</surname> <given-names>JP</given-names></string-name>, <string-name><surname>Caudarella</surname> <given-names>R</given-names></string-name></person-group>. <article-title>Utility of the trabecular bone score (TBS) in secondary osteoporosis</article-title>. <source>Endocrine</source>. <year>2014</year> <month>Nov</month>;<volume>47</volume>(<issue>2</issue>):<fpage>435</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1007/s12020-014-0280-4</pub-id><pub-id pub-id-type="pmid">24853880</pub-id><issn>1355-008X</issn></mixed-citation></ref>
<ref id="b22"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Geusens</surname> <given-names>PP</given-names></string-name>, <string-name><surname>de Nijs</surname> <given-names>RN</given-names></string-name>, <string-name><surname>Lems</surname> <given-names>WF</given-names></string-name>, <string-name><surname>Laan</surname> <given-names>RF</given-names></string-name>, <string-name><surname>Struijs</surname> <given-names>A</given-names></string-name>, <string-name><surname>van Staa</surname> <given-names>TP</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Prevention of glucocorticoid osteoporosis: a consensus document of the Dutch Society for Rheumatology</article-title>. <source>Ann Rheum Dis</source>. <year>2004</year> <month>Mar</month>;<volume>63</volume>(<issue>3</issue>):<fpage>324</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1136/ard.2003.008060</pub-id><pub-id pub-id-type="pmid">14962971</pub-id><issn>0003-4967</issn></mixed-citation></ref>
<ref id="b23"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Papaioannou</surname> <given-names>A</given-names></string-name>, <string-name><surname>Morin</surname> <given-names>S</given-names></string-name>, <string-name><surname>Cheung</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Atkinson</surname> <given-names>S</given-names></string-name>, <string-name><surname>Brown</surname> <given-names>JP</given-names></string-name>, <string-name><surname>Feldman</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal>; <collab>Scientific Advisory Council of Osteoporosis Canada</collab></person-group>. <article-title>2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary</article-title>. <source>CMAJ</source>. <year>2010</year> <month>Nov</month>;<volume>182</volume>(<issue>17</issue>):<fpage>1864</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1503/cmaj.100771</pub-id><pub-id pub-id-type="pmid">20940232</pub-id><issn>0820-3946</issn></mixed-citation></ref>
<ref id="b24"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Rizzoli</surname> <given-names>R</given-names></string-name></person-group>. <article-title>Nutrition: its role in bone health</article-title>. <source>Best Pract Res Clin Endocrinol Metab</source>. <year>2008</year> <month>Oct</month>;<volume>22</volume>(<issue>5</issue>):<fpage>813</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1016/j.beem.2008.08.005</pub-id><pub-id pub-id-type="pmid">19028358</pub-id><issn>1521-690X</issn></mixed-citation></ref>
<ref id="b25"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Holick</surname> <given-names>MF</given-names></string-name>, <string-name><surname>Binkley</surname> <given-names>NC</given-names></string-name>, <string-name><surname>Bischoff-Ferrari</surname> <given-names>HA</given-names></string-name>, <string-name><surname>Gordon</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Hanley</surname> <given-names>DA</given-names></string-name>, <string-name><surname>Heaney</surname> <given-names>RP</given-names></string-name>, <etal>et al.</etal>; <collab>Endocrine Society</collab></person-group>. <article-title>Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2011</year> <month>Jul</month>;<volume>96</volume>(<issue>7</issue>):<fpage>1911</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2011-0385</pub-id><pub-id pub-id-type="pmid">21646368</pub-id><issn>0021-972X</issn></mixed-citation></ref>
<ref id="b26"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Kocjan</surname> <given-names>T</given-names></string-name>, <string-name><surname>Preželj</surname> <given-names>J</given-names></string-name>, <string-name><surname>Pfeifer</surname> <given-names>M</given-names></string-name>, <string-name><surname>Sever</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Čokolič</surname> <given-names>M</given-names></string-name>, <string-name><surname>Zavratnik</surname> <given-names>A</given-names></string-name></person-group>. <article-title>Guidelines for the detection and treatment of osteoporosis</article-title>. <source>Zdr Vestn</source>. <year>2013</year>;<volume>82</volume>:<fpage>207</fpage>–<lpage>17</lpage>.<issn>1318-0347</issn></mixed-citation></ref>
<ref id="b27"><mixed-citation publication-type="unknown" specific-use="unparsed"><person-group person-group-type="author"><string-name><surname>Saag</surname> <given-names>KG</given-names></string-name>, <string-name><surname>Wagman</surname> <given-names>RB</given-names></string-name>, <string-name><surname>Geusens</surname> <given-names>P</given-names></string-name>, <string-name><surname>Adachi</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Messina</surname> <given-names>OD</given-names></string-name>, <string-name><surname>Emkey</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study.</article-title> Lancet Diabetes Endocrinol. <year>2018</year> Apr 6. pii: S2213–8587(18)30075–5. doi: <pub-id pub-id-type="doi">10.1016/S2213–8587(18)30075–5</pub-id>. [Epub ahead of print]</mixed-citation></ref>
<ref id="b28"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Saag</surname> <given-names>KG</given-names></string-name>, <string-name><surname>Shane</surname> <given-names>E</given-names></string-name>, <string-name><surname>Boonen</surname> <given-names>S</given-names></string-name>, <string-name><surname>Marín</surname> <given-names>F</given-names></string-name>, <string-name><surname>Donley</surname> <given-names>DW</given-names></string-name>, <string-name><surname>Taylor</surname> <given-names>KA</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Teriparatide or alendronate in glucocorticoid-induced osteoporosis</article-title>. <source>N Engl J Med</source>. <year>2007</year> <month>Nov</month>;<volume>357</volume>(<issue>20</issue>):<fpage>2028</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa071408</pub-id><pub-id pub-id-type="pmid">18003959</pub-id><issn>0028-4793</issn></mixed-citation></ref>
<ref id="b29"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Burkard</surname> <given-names>D</given-names></string-name>, <string-name><surname>Beckett</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kourtjian</surname> <given-names>E</given-names></string-name>, <string-name><surname>Messingschlager</surname> <given-names>C</given-names></string-name>, <string-name><surname>Sipahi</surname> <given-names>R</given-names></string-name>, <string-name><surname>Padley</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Effects of bone remodeling agents following teriparatide treatment</article-title>. <source>Osteoporos Int</source>. <year>2018</year> <month>Jun</month>;<volume>29</volume>(<issue>6</issue>):<fpage>1351</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi" specific-use="author">10.1007/s00198–018–4434–8</pub-id>; <comment>Epub ahead of print</comment>. <pub-id pub-id-type="doi">10.1007/s00198-018-4434-8</pub-id><pub-id pub-id-type="pmid">29541794</pub-id><issn>0937-941X</issn></mixed-citation></ref>
<ref id="b30"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>McClung</surname> <given-names>MR</given-names></string-name>, <string-name><surname>Wagman</surname> <given-names>RB</given-names></string-name>, <string-name><surname>Miller</surname> <given-names>PD</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>A</given-names></string-name>, <string-name><surname>Lewiecki</surname> <given-names>EM</given-names></string-name></person-group>. <article-title>Observations following discontinuation of long-term denosumab therapy</article-title>. <source>Osteoporos Int</source>. <year>2017</year> <month>May</month>;<volume>28</volume>(<issue>5</issue>):<fpage>1723</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1007/s00198-017-3919-1</pub-id><pub-id pub-id-type="pmid">28144701</pub-id><issn>0937-941X</issn></mixed-citation></ref>
<ref id="b36"><note><p>TODO: fix</p></note></ref>
</ref-list>
</back>
</article>
